Filters

H-J Malling

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Allergy|June 29, 2011
European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'M A Calderón, D Larenas, J Kleine-Tebbe, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Allergy|June 29, 2011
European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'M A Calderón, D Larenas, J Kleine-Tebbe, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.
Pageof 9
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us